SomnoMed Investor Relations Material
Latest events
H1 2025
SomnoMed
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SomnoMed Limited
Access all reports
SomnoMed Limited is an Australian-based medical device company, publicly listed on the Australian Stock Exchange, specializing in the development and manufacturing of oral devices for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders. The company's product portfolio includes a range of custom-made oral appliances such as the SomnoDent series (Avant, Classic, Flex, Fusion, Herbst Advance Elite, and Herbst Advance), SomMorning Repositioner, SomnoBrux, and SomTabs for cleaning oral appliances. The company is headquartered in Sydney, Australia, and its shares are listed on the Australian Stock Exchange.
Key slides for SomnoMed Limited
H1 2025
SomnoMed Limited
H1 2025
SomnoMed Limited
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
SOM
Country
🇦🇺 Australia